Publications: Haemophilus influenzae

2000 to Present:

 Top of Page

1995-1999:

  • Centers for Disease Control and Prevention. Achievements in public health, 1900-1999: Impact of vaccines universally recommended for children – United States, 1990-1999. MMWR Morb Mortal Wkly Rep. 1999;48(12);243-8.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 1999.
  • Jafari HS, Adams WG, Robinson KA, Plikaytis BD, Wenger JD. Efficacy of Haemophilus influenzae type b conjugate vaccines and persistence of disease in disadvantaged populations. The Haemophilus Influenzae Study Group. Am J Public Health. 1999;89:364-8.
  • Bisgard K, Kao A, Leake J, Strebel PM, Perkins BA, Wharton M. Haemophilus influenzae disease in the United States, 1994-1995: Near disappearance of a vaccine-preventable childhood disease. Emerg Infect Dis. 1998;4:229-37.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 1998.
  • Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b disease among infants and children — United States, 1987-1997. MMWR Morb Mortal Wkly Rep. 1998;47:993-8.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 1997.
  • Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b disease among infants and children — United States, 1987-1995. MMWR Morb Mortal Wkly Rep. 1996;45(42):901-6.
  • Urwin G, Krohn JA, Deaver-Robinson K, Wenger JD, Farley MM, and the Influenzae study group. Invasive Haemophilus influenzae serotype f disease: Clinical and epidemiological characteristics in the Hib vaccine era. Clin Infect Dis. 1996;22:1069-76.
  • Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b disease among infants and children-United States, 1993-1994. MMWR Morb Mortal Wkly Rep. 1995;44(29):545-50.

 Top of Page

1988 – 1994:

  • Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b disease among infants and children–United States, 1987-1993. MMWR Morb Mortal Wkly Rep. 1994;43(8):144-8.
  • Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA. 1993;269:221-6.
  • Farley MM, Stephens DS, Brachman PS Jr, Harvey RC, Smith JD, Wenger JD. Invasive Haemophilus influenzae disease in adults: Population-based surveillance. Ann Intern Med. 1992;116:806-12.
  • Farley MM, Stephens DS, Harvey RC, Sikes RK, Wenger JD, and the CDC Meningitis Surveillance Group. Incidence and clinical characteristics of invasive Haemophilus influenzae in adults. J Infect Dis. 1992;165:S42-3.
  • Wenger JD, Pierce R, Deaver K, et al. Invasive Haemophilus influenzae disease: A population-based evaluation of the role of capsular polysaccharide serotype. J Infect Dis. 1992;165 [Suppl. 1]:S34-5.
  • Wenger JD, Pierce R, Deaver KA, et al. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in US children aged 18-59 months. Lancet. 1991;338:395-8.
  • Wenger JD, Harrison LH, Hightower A, Broome CV. Day care characteristics associated with Haemophilus influenzae Am J Public Health. 1990;80:1455-8.
  • Harrison LH, Broome CV, Hightower AW. Haemophilus influenzae type b polysaccharide vaccine: an efficacy study. Pediatrics. 1989;84:255-61.
  • Harrison LH, Broome CV, Hightower AW, et al. A day care-based study of the efficacy of Haemophilus b polysaccharide vaccine. JAMA. 1988;260:1413-8.

 Top of Page